Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodality Therapy for Recurrent High Risk Prostate Cancer: A Phase II Study

NCT00734851 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00734851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodality Therapy for Recurrent High Risk Prostate Cancer: A Phase II Study
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2008
Completion date
November 30, 2014
Enrollment
36 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer